High risk HPV persists after treatment of genital papillomavirus infection but not after treatment of cervical intraepithelial neoplasia

References

• Meyers C, Frattini MG, Hudson JB, Laimins LA. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992; 257: 971–3
   PubMed Web of Science ®Google Scholar
• Mertz GJ, Benedetti J, Ashley R, Selke SA., Corey L. Risk factors for the transmission of genital herpes. Ann Intern Med 1992; 116: 197–202
   PubMed Web of Science ®Google Scholar
• Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333: 770–5
   PubMed Web of Science ®Google Scholar
• Strand A, Rylander E, Evander M, Wadell G. Genital human papillomavirus infection among patients attending an STD clinic. Genitourin Med 1993; 69: 446–9
   PubMedGoogle Scholar
• Karlsson R, Johansson M, Edlund K, et al. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population based study. Sex Transm Dis 1995; 22: 119–27
   PubMed Web of Science ®Google Scholar
• Bavin PJ., Giles JA., Derry A, et al. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with mild dyskaryotic smear report. Br J Cancer 1993; 67: 02–5
   Google Scholar
• Cox JT., Lorincz AT., Schiffamn MH, Sherman ME., Cullen A., Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 172: 946–54
   PubMed Web of Science ®Google Scholar
• Strand A., Brinkeborn RM, Siboulet A. Topical treatment of genital warts in men. an open study of podophyllotoxin cream compared with solution. Genitourin Med 1995; 71: 387–90
   Google Scholar
• Lungo O., Jr, Wright TC., Silverstein S. Typing of human papillomavirus by polymerase chain reaction amplification with LI consensus primers and RFLP analysis. Mol Cell Probes 1992; 6: 145–52
   Google Scholar
• Saiki RK., Scarf S., Faloona F, et al. Enzymatic amplification of b-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350–4
   PubMed Web of Science ®Google Scholar
• Chua KL., Hjerpe A. Polymerase chain reaction (PCR) analysis of human papillomavirus (HPV) in archival Pap smears. Analyt Quant Histol 1995; 17: 221–9
   Google Scholar
• dc Roda Husman A-M., Walboomers J MM, van den Brule A JC, Meijer C JLM, Snijders P JF. The use of general primers GPS and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection bv PCR. J Gen Virol 1995; 76: 1057–62
   Google Scholar
• Erlich HA., Gelfand D., Sninsky JJ. Recent advances in the polymerase chain reaction. Science 1991; 252: 1643–56
   PubMed Web of Science ®Google Scholar
• Gissman L., Wolnik L., Ikenberg H, et al. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and : n some cervical cancers. Proceedings of the National Academy of Sciences of the USA 1983; 80: 560–3
   PubMed Web of Science ®Google Scholar
• Bauer HM., Hildesheim A, Schiffman MH, et al. Determinants of genital papillomavirus infection in low-risk women in Portland. Oregon. Sex Transm Dis 1993; 20: 274–8
   PubMed Web of Science ®Google Scholar
• Voog E, Bolmstedt A, Olofsson S, Ryd W, Löwhagen G-B. Human papillomavirus infection among women attending an STD clinic correlated to reason for attending, presence of clinical signs, concomitant infections and abnormal cytology. Acta Derm Venereol 1995; 75: 75–8
   Google Scholar
• Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327: 1272–8
   PubMed Web of Science ®Google Scholar
• Bekassy Z, Ahlgren M, Eriksson M, Lindh E. Carbon dioxide laser miniconization for treatment of human papillomavirus infection associated with cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand 1995; 74: 822–6
   PubMed Web of Science ®Google Scholar
• Elfgren K, Bistoletti R, Dillner L., Walboomers J MM, Meijer C JLM, Dillner J. Conization of CIN is followed by a disappearance of HPV DNA and a decline of serum and cervical mucus antibodies against HPV antigens. Am J Obstet Gynecol 1996; 174: 937–42
   PubMed Web of Science ®Google Scholar
• Wikström A, van Doornum GJ, Quint WG, Schiller JT, Dillner J. Identification of human papillomavirus seroconversions. J Gen Virol 1995; 76: 529–39
   PubMed Web of Science ®Google Scholar
• Benton C, Shahidullah H, Hunter J. Human papillomavirus in immunosuppressed. Papillomavirus Rep 1992; 3: 23–36
   Google Scholar
• Schneider A, Kirchmayr R, Villiers E-MD, Gissmann L. Subclinical human papillomavirus infection in male partners of female carriers. J Urol 1988; 140: 1431–4
   PubMed Web of Science ®Google Scholar
• Gath DH, Hallam N., Mynors-Wallis L., Day A., Bond S AK. Emotional reactions in women attending a UK colposcopy clinic. J Epidemiol Communitv Health 1995; 49: 79–83
   PubMed Web of Science ®Google Scholar
• Macgregor JE., Campbell MK., Mann E MF, Swanson KY. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. BMJ 1994; 308: 3104–9
   Google Scholar
• Remmink AJ, Walboomers J MM, Helmerhorst T JM, et al. The presence of persistent high-risk HPV genotypes in dys-plastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61: 306–11
   PubMed Web of Science ®Google Scholar